Preparative Purification Solutions in Drug Discovery Synthesis
Drug discovery and synthesis are crucial steps in the drug development process and having the proper tools to quickly create and purify drug candidates to inform both upstream and downstream decisions are paramount. However, the field of preparative purification has expanded into many different methodologies depending on your drug modality, that it can be challenging to make sense of the different prep methods. Shimadzu has a wide array of instrumentation that can be tailored to anyone’s preparative purification needs.
Attend this webinar on Wednesday, April 16th at 2:00 pm to learn more about our solutions for the preparative purification in the drug discovery space.
We will host a Q&A session after the presentation to address any questions or comments.
Presenter: Kevin Wons (Market Manager - Pharma/BioPharma, Shimadzu Scientific Instruments)
Kevin joined Shimadzu in early 2024 as Market Manager for Pharma/BioPharma. Prior to joining Shimadzu, he spent 6 years at AstraZeneca in the Analytical Sciences Department for product and process characterization for biologics in the AstraZeneca pipeline. Kevin has applications experience with HPLC and LC-MS to do Tryptic Peptide Mapping, Intact Mass Analysis, Subunit Mass Analysis, and Oligosaccharide Profiling. For his last 3 years, he acted as the Glycan Subject Matter Expert (SME) while at AstraZeneca. His work experience also includes Maryland Psychiatric Research Center, where he prepared animal tissue samples such as Brain, Liver, Blood, and Placenta to measure kynurenine pathway metabolites on GC/MS and HPLC. He has a Master’s degree in Professional Studies (MPS) focused on Biotechnology which prepares science professionals to fill management and leadership roles.
